I

    International Business Machines (IBM)

    Official site

    TECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE

    $235.59
    -3.20 (-1.34%)

    Market Cap: $221.96B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +3.41%
    Streak
    14 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$2.89
    Range$2.78 - $3.12
    20 analysts
    EPS Revisions
    6
    0
    7d
    6
    9
    30d
    EPS Estimate Drift
    90d ago$2.94+1.6%
    60d ago$2.93+1.3%
    30d ago$2.81-2.6%
    7d ago$2.89+0.0%
    Current$2.89
    Revenue Consensus
    $16.8B
    Range$16.7B - $17.1B
    18 analysts
    Dec 31, 2026
    EPS Consensus$4.69
    Range$4.45 - $5.00
    24 analysts
    Revenue Consensus
    $20.7B
    Range$20.2B - $21.3B
    22 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.69---
    Sep 26EST
    		-$2.89---
    Jun 26
    		$2.93$2.93+0.00%Beat+4.6%
    Mar 26
    		$1.91$1.81+5.52%Beat+19.4%
    Dec 25
    		$4.52$4.29+5.36%Beat+15.3%
    Sep 25
    		$2.65$2.45+8.16%Beat+15.2%
    Jun 25
    		$2.80$2.65+5.66%Beat+15.2%
    Mar 25
    		$1.60$1.43+11.89%Beat-4.8%
    Dec 24
    		$3.92$3.78+3.70%Beat+1.3%
    Sep 24
    		$2.30$2.23+3.14%Beat+4.5%
    Jun 24
    		$2.43$2.17+11.98%Beat+11.5%
    Mar 24
    		$1.68$1.60+5.00%Beat+23.5%
    Dec 23
    		$3.87$3.78+2.38%Beat+7.5%
    Sep 23
    		$2.20$2.13+3.29%Beat+21.5%
    Jun 23
    		$2.18$2.00+9.00%Beat-5.6%
    Mar 23
    		$1.36$1.24+9.68%Beat-2.9%
    Dec 22
    		$3.60$3.61-0.28%Miss+7.5%
    Sep 22
    		$1.81$1.80+0.56%Beat-28.2%
    Jun 22
    		$2.31$2.29+0.87%Beat-0.9%
    Mar 22
    		$1.40$1.42-1.41%Miss-20.9%
    Dec 21
    		$3.35$3.29+1.82%Beat+61.8%
    Sep 21
    		$2.52$2.51+0.40%Beat-2.3%
    Jun 21
    		$2.33$2.29+1.75%Beat+6.9%
    Mar 21
    		$1.77$1.65+7.27%Beat-3.8%
    Dec 20
    		$2.07$1.88+10.11%Beat-56.1%
    Sep 20
    		$2.58$2.58+0.00%Beat-3.7%
    Jun 20
    		$2.18$2.09+4.31%Beat-31.2%
    Mar 20
    		$1.84$1.80+2.22%Beat-18.2%
    Dec 19
    		$4.71$4.69+0.43%Beat-3.3%
    Sep 19
    		$2.68$2.66+0.75%Beat-21.6%
    Jun 19
    		$3.17$3.07+3.26%Beat+2.9%
    Mar 19
    		$2.25$2.24+0.45%Beat-8.2%
    Dec 18
    		$4.87$4.82+1.04%Beat-6.0%
    Sep 18
    		$3.42$3.40+0.59%Beat+3.6%
    Jun 18
    		$3.08$3.04+1.32%Beat+3.7%
    Mar 18
    		$2.45$2.42+1.24%Beat+2.9%
    Dec 17
    		$5.18$5.17+0.19%Beat+3.4%
    Sep 17
    		$3.30$3.28+0.61%Beat+0.3%
    Jun 17
    		$2.97$2.74+8.39%Beat-
    Mar 17
    		$2.38$2.35+1.28%Beat-
    Dec 16
    		$5.01$4.88+2.66%Beat-
    Sep 16
    		$3.29$3.23+1.86%Beat-

    Dividends

    Dividend Metrics

    Yield2.86%
    Annual/Share$6.74
    Payout Ratio42.61%
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+0.60%
    5Y CAGR+0.61%
    View IBM's full dividend history

    Key Metrics

    Valuation
    P/E Ratio19.62EV/EBITDA16.06x
    Price/FCF16.08xFCF Yield6.22%
    Profitability
    Profit Margin15.50%Operating Margin16.60%
    ROE34.50%ROIC12.83%
    Financial Health
    Debt/Equity1.80xInterest Coverage6.41x
    Current Ratio0.79xQuick Ratio0.74x
    Trading Statistics
    Beta0.70Avg Volume5.64M
    52-Week High$330.0952-Week Low$197.77

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$233.75
    SMA 20$233.97
    SMA 50$242.54
    SMA 200$261.84
    EMA 10$234.24
    EMA 20$233.97
    EMA 50$239.24
    EMA 200$253.35

    MACD

    Line: -0.74Signal: -1.81Hist: 1.07

    ADX

    ADX: 11.0+DI: 24.3-DI: 21.7

    Aroon & PSAR

    Aroon Up48.0
    Aroon DownN/A
    PSAR$224.49

    Bollinger Bands

    Upper Band$240.87
    Lower Band$227.08
    %B Position589%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    50.5

    Momentum Oscillators

    Stoch %K51.0
    Stoch %D42.9
    Williams %R-43.1
    ROC (10d)0.5%
    Momentum1.27
    CCI (20d)67.3
    MFI (14d)47.9

    Volatility Measures

    ATR (14d)$7.51(3.2%)
    StdDev (20d)3.45
    Hist Vol28.9%(Moderate)

    Volume Flow

    VWAP$236.59
    OBV103.0M
    AD Line-1.6B
    CMF (20d)-0.140

    Volume Metrics

    Avg Vol (20d)5.3M
    Vol Ratio0.7x
    VWMA (20d)$233.68

    Pivot Points

    R3$251.94
    R2$246.37
    R1$242.58
    Pivot Point$237.02
    S1$233.22
    S2$227.66
    S3$223.87

    Advanced Oscillators

    TSI-2.35
    Ultimate Osc47.8
    KST-10.52

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17.16B$15.92B$19.69B$16.33B$16.98B$14.54B$17.55B$14.97B$15.77B$14.46B$17.38B$14.75B
    Cost of Revenue$7.25B$6.97B$7.76B$6.97B$7.00B$6.51B$7.11B$6.55B$6.82B$6.72B$7.11B$6.73B
    Gross Profit$9.91B$8.95B$11.93B$9.36B$9.98B$8.03B$10.44B$8.42B$8.95B$7.74B$10.27B$8.02B
    Operating Expenses$6.94B$7.09B$7.31B$6.44B$6.87B$6.42B$6.71B$8.79B$6.30B$6.24B$5.38B$5.95B
    R&D$2.15B$2.00B$1.91B$1.86B$1.88B$1.70B$1.67B$1.64B$1.60B$1.58B$1.51B$1.50B
    SG&A$4.98B$5.09B$5.46B$4.75B$5.03B$4.89B$4.87B$4.91B$4.94B$4.97B$4.79B$4.46B
    Operating Income$2.97B$1.86B$4.62B$2.92B$3.11B$1.61B$3.73B$-373,000,000$2.65B$1.50B$4.88B$2.07B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$486.00M$473.00M$478.00M$492.00M$510.00M$455.00M$424.00M$429.00M$427.00M$432.00M$405.00M$412.00M
    Income Before Tax$2.48B$1.39B$4.14B$2.43B$2.60B$1.16B$3.31B$-802,000,000$2.22B$1.07B$3.76B$1.87B
    Income Tax Expense$313.00M$172.00M$-1,435,000,000$686.00M$404.00M$103.00M$380.00M$-485,000,000$389.00M$-502,000,000$474.00M$159.00M
    Net Income$2.17B$1.22B$5.60B$1.74B$2.19B$1.05B$2.91B$-330,000,000$1.83B$1.60B$3.29B$1.70B
    EBITDA$4.32B$3.13B$5.92B$4.21B$4.37B$2.79B$4.84B$895.00M$3.80B$2.64B$6.04B$3.38B
    EBIT$2.97B$1.86B$4.62B$2.92B$3.11B$1.61B$3.73B$-373,000,000$2.65B$1.50B$4.88B$2.29B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Accenture: My March Fair Value Was Too High. The Stock Is Still Too Cheap

    I overstated March fair value, cutting blended Vulcan BFV to $227.62 (-22%), stock trading at $176.89, down ~17% since March and bottoming at $118.15 in June Fiscal Q2 showed strength - record bookings $22.11B (+6%), book-to-bill 1.2, free cash flow $3.7B, adjusted operating margin +30bps, management raised FY FCF guide by $1.0B Fiscal Q3 mixed - bookings -3% LC to $19.32B, consulting +1% LC to $9.3B, revenue +3% LC to $18.7B, operating margin 17.0% (+20bps), EPS $3.80 (+9%), FCF $3.6B, FY FCF guide $10.8-11.5B AI is both the biggest opportunity and structural risk - automation can compress hours-based economics, but 104 client engagements >$100M (+13%) and ~$38B RPO argue durable integration demand Primary downside risk is M&A cadence - Vulcan normalizes $2.53B annual acquisition burden, implying normalized FCFF ~$9.13B; management's FY26 acquisition plan near ~$9B could materially lower fair value further

    Unknown Author
    •
    8/18/26
    •
    163
    value investing
    Also mentions:
    IBM
    CTSH
    INFY

    Accenture: The Dividend Compounder Trading at a Value Price

    ACN trades at 14.4x forward earnings with a 100th-percentile EPS predictability score and 40x interest coverage. The market is pricing it like a utility. The business is still growing bookings at double digits. The Chowder Rule on ACN is 16.2%, clearing the 15% quality compounder threshold. Forward yield of 3.0% combined with 13.1% five-year dividend growth rate makes the income case as strong as the value case. Gen AI bookings at Accenture nearly doubled to $5.9B in FY25. The AI disruption narrative is backwards: enterprise clients are hiring ACN to implement AI, not replacing it with AI. Blended fair value: $292. Current price near $213. That is a 27% discount on a business with Quality Score 94, Safety Score 97.36, and negative net working capital risk. Strong Buy zone is active. The invalidation trigger is specific: two consecutive quarters of declining bookings plus a guidance cut below 2% FY26 revenue growth. Until that happens, the drawdown is price compression, not franchise deterioration.

    Unknown Author
    •
    3/10/26
    •
    339
    value investing
    IT Services
    AI Adoption
    Also mentions:
    IBM
    INFY
    CTSH

    Government Contracts

    Gov Obligations (TTM)
    $1.10B
    Gov Obligations / Revenue
    1.6%
    Obligations YoY
    -12.6%
    Active Awards
    238
    New Awards (TTM)
    67
    Avg Remaining Term
    5.6 mo

    Top agency: Department of Defense at 26.8% of trailing twelve month obligations across 22 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    28321325FDS030162Social Security AdministrationSocial Security Administration$77.40MSep 26, 2025
    70SBUR25F00000032Department of Homeland SecurityU.S. Citizenship and Immigration Services$27.58MAug 8, 2025
    FA714626C0015Department of DefenseDepartment of the Air Force$24.44MMar 31, 2026
    70RDA125FC0000061Department of Homeland SecurityOffice of Procurement Operations$21.03MSep 26, 2025
    N0003926FF003Department of DefenseDepartment of the Navy$15.61MApr 21, 2026
    70FA3126F00000046Department of Homeland SecurityFederal Emergency Management Agency$15.29MJul 8, 2026
    HC108426F0008Department of DefenseDefense Information Systems Agency$12.92MOct 27, 2025
    47QFEA26F0004General Services AdministrationFederal Acquisition Service$11.84MApr 1, 2026
    47QPCA26F0005General Services AdministrationFederal Acquisition Service$10.16MOct 22, 2025
    205AE926F00080Department of the TreasuryInternal Revenue Service$8.80MJul 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Edwards Lifesciences SVP Andrew M. Dahl Sells 544 Shares Under Employee Stock Purchase Plan

    Andrew M. Dahl, Senior Vice President and Corporate Controller at Edwards Lifesciences Corp, sold 544 shares of common stock at $91.055 per share on August 31, 2026, under the company's Employee Stock Purchase Plan. Following this transaction, Dahl directly owns 14,868.41 shares of Edwards Lifesciences. This transaction was disclosed via an SEC Form 4 and reflects routine quarterly share acquisitions.

    Kalkine Media•9/1/26•
    Neutral

    Analog Devices, Inc. $ADI Shares Sold by Royal London Asset Management Ltd.

    Royal London Asset Management Ltd. reduced its stake in Analog Devices (NASDAQ:ADI) by 3.1% in the second quarter, selling 16,780 shares, but still holds 521,402 shares valued at approximately $207.1 million. Despite this sale, institutional investors collectively own 86.81% of ADI, and analysts maintain a consensus "Buy" rating with an average price target of $454.63. The company recently exceeded quarterly expectations with strong EPS and revenue growth, and declared a quarterly dividend of $1.10 per share.

    MarketBeat•8/30/26•
    Neutral

    Avestar Capital LLC Buys 3,757 Shares of International Business Machines Corporation $IBM

    Avestar Capital LLC increased its stake in International Business Machines Corporation (IBM) by 63.9% in the second quarter, purchasing an additional 3,757 shares to bring its total holdings to 9,641 shares, valued at $2.71 million. Institutional investors collectively own 58.96% of IBM, and analysts generally rate the stock a "Moderate Buy" with an average price target of $265.40. IBM recently reported quarterly EPS of $2.93, matching expectations, but revenue of $17.16 billion fell short of forecasts, and the company declared a quarterly dividend of $1.69.

    MarketBeat•8/29/26•
    Neutral

    Legal & General Group Plc Acquires Shares of 188,444 Tyler Technologies, Inc. $TYL

    Legal & General Group Plc has acquired 188,444 shares of Tyler Technologies, Inc. (NYSE:TYL) worth approximately $55.1 million, establishing a 0.46% stake in the company. Institutional investors now collectively own 93.3% of Tyler Technologies. Despite a recent COO stock sale, analysts maintain a "Moderate Buy" rating with an average price target of $456.72 for TYL.

    MarketBeat•8/29/26•
    Neutral

    Hartline Investment Corp Boosts Stake in International Business Machines Corporation $IBM

    Hartline Investment Corp significantly increased its stake in International Business Machines Corporation (IBM) by 2,914.5% in the second quarter, now holding 46,514 shares valued at $13.08 million, making IBM its 22nd largest holding. Institutional ownership of IBM remains high at 58.96%, with various investors adjusting their positions. Despite mixed sentiment from analysts and a slight revenue miss, IBM reported in-line EPS, declared a quarterly dividend of $1.69, and maintains a "Moderate Buy" consensus rating with an average price target of $265.40.

    MarketBeat•8/28/26•
    Somewhat-Bullish

    Frequently Asked Questions About IBM

    What is IBM's current dividend yield?
    International Business Machines (IBM) has a current dividend yield of 2.86%.
    Does IBM pay dividends?
    Yes, International Business Machines pays dividends with a current yield of 2.86%.
    What is IBM's P/E ratio?
    International Business Machines has a price-to-earnings (P/E) ratio of 19.62.
    What is IBM's market cap?
    International Business Machines (IBM) has a market capitalization of $221.96B with a current stock price of $235.59.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In